Phenotypic Identification of Platelet-Type von Willebrand Disease and Its Discrimination from Type 2B von Willebrand Disease: A Question of 2B or Not 2B? A Story of Nonidentical Twins? Or Two Sides of a Multidenominational or Multifaceted Primary-Hemostasis Coin?

ABSTRACT

Platelet-type von Willebrand disease (PT-VWD) and type 2B von Willebrand disease (2B-VWD) have different etiologies although both present with a similar clinical bleeding and basic laboratory phenotype. Both PT-VWD and 2B-VWD represent gain-of-function mutations that lead to enhanced binding between plasma von Willebrand factor (VWF) and its platelet ligand, glycoprotein Ib α (GP1BA). However, 2B-VWD results from a functionally abnormal VWF molecule arising from mutations in the VWF gene, whereas PT-VWD is caused by hyperresponsive platelets resulting from mutations in the platelet GP1BA gene. A definitive diagnosis of PT-VWD versus 2B-VWD is critical for treatment decisions (as differential therapies might be respectively required) and also for family counseling. However, laboratory discrimination of PT-VWD versus 2B-VWD is problematic because simple phenotypic testing will not permit their differentiation, and the more complex testing approaches that might permit their differentiation are rarely applied, or are perhaps poorly applied. Although differential identification of PT-VWD versus 2B-VWD can most definitively be achieved by identifying the gene defect at either the VWF or GP1BA loci, such tests are not commonly available, not always successful, and even if available and successful might not be readily available to serve time-critical treatment decisions. Accordingly, simple laboratory tools to enable discrimination of the two disorders would be a valuable addition to the test repertoire of the hemostasis laboratory. This article provides a review of PT-VWD-related literature and an overview of a phenotypic laboratory test process that should enable the effective identification of PT-VWD and its discrimination from 2B-VWD.

KEYWORDS

von Willebrand disease - VWD - von Willebrand factor - VWF - platelet-type VWD - pseudo-VWD - PT-VWD - GP1BA - GPIBA - RIPA - type 2B VWD

REFERENCES

• 1 Favaloro E J. Laboratory identification of von Willebrand disease: technical and scientific perspectives.  Semin Thromb Hemost. 2006;  32 456-471
• 2 Sadler J E, Mannucci P M, Berntorp E et al.. Impact, diagnosis and treatment of von Willebrand disease.  Thromb Haemost. 2000;  84 160-174
• 3 Othman M. Platelet type-von Willebrand disease and type 2B von Willebrand disease: a story of non-identical twins when two different genetic abnormalities evolve into similar phenotypes.  Semin Thromb Hemost. 2007;  33 780-786
• 4 Franchini M, Montagnana M, Lippi G. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease.  Int J Lab Hematol. 2008;  30 91-94
• 5 Miller J L. Platelet-type von Willebrand disease.  Thromb Haemost. 1996;  75 865-869
• 6 Federici A B. Management of inherited von Willebrand disease in 2006.  Semin Thromb Hemost. 2006;  32 616-625
• 7 Ruggeri Z M, Pareti F I, Mannucci P M, Ciavarella N, Zimmerman T S. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand disease.  N Engl J Med. 1980;  302 1047-1051
• 8 Castaman G, Federici A B, Rodeghiero F, Mannucci P M. von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.  Haematologica. 2003;  88 94-108
• 9 Enayat M S, Guilliatt A M, Lester W, Wilde J T, Williams M D, Hill F G. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance.  Br J Haematol. 2006;  133 664-666
• 10 Favaloro E J. 2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease.  Br J Haematol. 2006;  135 141-142
• 11 Whalley I N, Perry D J. 2B or not 2B? Differential identification of type 2B versus pseudo-von Willebrand disease.  Br J Haematol. 2007;  136 345
• 12 Favaloro E J. 2B or not 2B? Differential identification of type 2B versus pseudo-von Willebrand disease-response to Whalley and Perry.  Br J Haematol. 2007;  136 345-346
• 13 Guermazi S, Conard J, Samama M M, Dellagi K. Type 2B and pseudo type 2B von Willebrand disease: a report of three cases.  Pathol Biol. 2006;  54 159-165
• 14 Othman M, Lillicrap D. Distinguishing between non-identical twins: platelet type and type 2B von Willebrand disease.  Br J Haematol. 2007;  138 665-666
• 15 Nurden P, Lanza F, Bonnafous-Faurie C, Nurden A. A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene.  Thromb Haemost. 2007;  97 319-321
• 16 Weiss H J, Meyer D, Rabinowitz R, Pietu J P, Vicic W J, Rogers J. Pseudo-von Willebrand's disease: an intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced absorption of its high-molecular-weight multimers.  N Engl J Med. 1982;  306 326-333
• 17 Miller J L, Castella A. Platelet type von Willebrand disease: characterization of a new bleeding disorder.  Blood. 1982;  60 790-794
• 18 Favaloro E J. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand disease.  Blood Rev. 1999;  13 185-204
• 19 Sadler J E, Budde U, Eikenboom J C et al.. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.  J Thromb Haemost. 2006;  4 2103-2114
• 20 ISTH VWD mutation database. Available at: http://www.vwf.group.shef.ac.uk/ Accessed December 6, 2007
• 21 Ginsburg D, Sadler J E. Von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.  Thromb Haemost. 1993;  69 177-184
• 22 Miller J L, Cunningham D, Lyle V A, Finch C N. Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.  Proc Natl Acad Sci U S A. 1991;  88 4761-4765
• 23 Russell S D, Roth G J. von Willebrand disease: a mutation in the platelet glycoprotein Ibα gene associated with a hyperactive surface receptor.  Blood. 1993;  81 1787-1791
• 24 Takahashi H, Murata M, Moriki T et al.. Substitution of Val for Met at residue 239 of platelet glycoprotein Ib α in Japanese patients with platelet-type von Willebrand disease.  Blood. 1995;  85 727-733
• 25 Kunishima S, Heaton D C, Naoe T et al.. De novo mutation of the platelet glycoprotein Ib alpha gene in a patient with pseudo-von Willebrand disease.  Blood Coagul Fibrinolysis. 1997;  8 311-315
• 26 Matsubara Y, Murata M, Sugita K, Ikeda Y. Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease.  J Thromb Haemost. 2003;  1 2198-2205
• 27 Favaloro E J, Patterson D, Denholm A et al.. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease from type 2B VWD using a simplified ristocetin-induced-platelet-agglutination (RIPA) mixing assay and confirmed by genetic analysis.  Br J Haematol. 2007;  139 623-626
• 28 Othman M, Notley C, Lavender F L et al.. Identification and functional characterisation of a novel 27bp deletion in the macroglycopeptide-coding region of the GPIb alpha gene resulting in platelet-type von Willebrand disease.  Blood. 2005;  105 4330-4336
• 29 BSS database. Available at: http://www.bernardsoulier.org/index.html Accessed December 6, 2007
• 30 Sadler J E. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.  Thromb Haemost. 1994;  71 520-525
• 31 Sadler J E, Gralnick H R. Commentary: a new classification for von Willebrand Disease.  Blood. 1994;  84 676-679
• 32 Sadler J E. von Willebrand factor: two sides of a coin.  J Thromb Haemost. 2005;  3 1702-1709
• 33 Balduini C L, Savoia A. Inherited thrombocytopenias: molecular mechanisms.  Semin Thromb Hemost. 2004;  30 513-523
• 34 Barbui T, Baudo F, Ciavarella N et al.. (Italian Working Group). Spectrum of von Willebrand's disease: a study of 100 cases.  Br J Haematol. 1977;  35 101-112
• 35 Ruggeri Z M. Type IIB von Willebrand disease: a paradox explains how von Willebrand factor works.  J Thromb Haemost. 2004;  2 2-6
• 36 Hoffmeister K M, Felbinger T W, Falet H et al.. The clearance mechanism of chilled blood platelets.  Cell. 2003;  112 87-97
• 37 Hoffmeister K M, Josefsson E C, Isaac N A, Clausen H, Hartwig J H, Stossel T P. Glycosylation restores survival of chilled blood platelets.  Science. 2003;  301 1531-1534
• 38 Favaloro E J, Nair S C, Forsyth C J. Collection and transport of samples for laboratory testing in von Willebrand's disease (VWD): time for a reappraisal?.  Thromb Haemost. 2001;  86 1589-1590
• 39 Favaloro E J, Soltani S, McDonald J. Potential laboratory misdiagnosis of haemophilia and von Willebrand disorder due to cold activation of blood samples for testing.  Am J Clin Pathol. 2004;  122 686-692
• 40 Böhm M, Täschner S, Kretzschmar E, Gerlach R, Favaloro E J, Scharrer I. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand's disease.  Blood Coagul Fibrinolysis. 2006;  17 39-45
• 41 Favaloro E J. Pre-analytical variables in coagulation testing.  Blood Coagul Fibrinolysis. 2007;  18 86-89
• 42 Refaai M A, Van Cott E M, Lukoszyk M, Hughes J, Eby C S. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.  Lab Hematol. 2006;  12 99-102
• 43 Hayward C PM, Eikelboom J. Platelet function testing: quality assurance.  Semin Thromb Hemost. 2007;  33 273-282
• 44 Scott J P, Montgomery R R. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the “neutral” monoclonal antibody binding assay.  Am J Clin Pathol. 1991;  96 723-728
• 45 Blackie C, Chalmers I, Perry D. 2B or not 2B? A case report: 222.  Br J Haematol. 2006;  133(Suppl 1) 88
• 46 Takahashi H, Handa M, Watanabe K et al.. Further characterization of platelet-type von Willebrand's disease in Japan.  Blood. 1984;  64 1254-1262